Affordable Access

deepdyve-link
Publisher Website

Adjuvant intravesical bacillus calmette-guérin therapy and survival among elderly patients with non-muscle-invasive bladder cancer.

Authors
  • Spencer, Benjamin A
  • McBride, Russell B
  • Hershman, Dawn L
  • Buono, Donna
  • Herr, Harry W
  • Benson, Mitchell C
  • Gupta-Mohile, Supriya
  • Neugut, Alfred I
Type
Published Article
Journal
Journal of oncology practice / American Society of Clinical Oncology
Publication Date
Mar 01, 2013
Volume
9
Issue
2
Pages
92–98
Identifiers
DOI: 10.1200/JOP.2011.000480
PMID: 23814517
Source
Medline
License
Unknown

Abstract

Despite guidelines recommending its use, BCG is administered to less than one quarter of eligible patients. This large population-based study found improved OS and BCSS were associated with use of adjuvant intravesical BCG among older patients with NMIBC. Better-designed clinical trials focusing on higher-grade cancers are needed to confirm these findings.

Report this publication

Statistics

Seen <100 times